Mr Langa joined Novo Nordisk in 2011 as senior director of Managed
Markets. In 2015 Mr Langa was promoted to corporate vice president of
Market Access in the US and in 2016 he was appointed Senior Vice
President of Market Access in the US. In this role he was responsible
for securing formulary access with key payer customers for Novo
Nordisk brands. In March 2017 Mr Langa was appointed senior vice
president, head of North America Operations and president of Novo
Nordisk Inc., and in August 2017 Mr Langa was promoted to executive
vice president, continuing his responsibilities as head of North
America Operations and president of Novo Nordisk Inc. Mr. Langa
represents Novo Nordisk Inc. on the Board of Directors of the trade
Mr Langa joined Novo Nordisk from GlaxoSmithKline, where he was the
Senior Director of Payer Marketing. Prior to GlaxoSmithKline Mr Langa
spent the majority of his career at Johnson and Johnson, where he held
various roles of increasing responsibility within Managed Markets,
Sales Leadership and Marketing.
Mr Langa graduated from Widener University, US, in 1989 and earned an
MBA from Fordham University, US, in 1997. Mr Langa also holds
professional certificates from The Wharton School, 2012, and Harvard
Business School, 2015.
Mr Langa is a US national, born October 1966.
NOVO NORDISK HQ
Novo Nordisk A/S Novo Alle 1 2880 Bagsværd
Denmark +45-4444-8888 CVR-no. 24256790